Testing for C. difficile is indicated in patients with diarrhea, especially after antibiotic use or healthcare exposure.

Currently, chemotherapy remains a common treatment for biliary tract cancers, which have a limited survival rate.

Shubham Pant, MD, MBBS, discussed the use of zanidatamab and the HERIZON-BTC-01 trial in HER2-positive biliary tract cancer ...

The FDA on Wednesday granted accelerated approval to zanidatamab (Ziihera), a bispecific antibody, for pretreated ...

Researchers estimate vaccines for enteric pathogens could prevent up to 8 to 12 courses of antibiotics per 100 vaccinated ...

Mercury toxicity occurs when the body is exposed to high levels of mercury, a toxic metal. Symptoms can vary depending on the ...

or whether it occurred before or after the initiation of antibiotic treatment. The reported incidence of diarrhea in extraintestinal infections can be questioned, because many cases of diarrhea ...

A resurgence of rare and dangerous parasites in Vietnam is alarming health experts, with infections linked to undercooked ...

“Patients need supportive treatment with hydration but do not need specific therapy ... People who have severe stomach cramps ...

Sarrah Strimel Bentley is an optimist – even when it comes to her journey with early breast cancer. The new mother and philanthropist discusses why she’s empowered to live a happy and healthy life.

The cumulative incidence of depression was higher among those with migraine during fall 2020 (15%) than in those without (12%).

The FDA has approved a new drug, zanidatamab, for adults with advanced biliary tract cancer, or BTC. Marketed under the brand name Ziihera, it is a first-of-a-kind treatment for patients with ...